Go Pro
→ AI insiders stockpile guns, gold & gas masks (From TradeSmith) (Ad)tc pixel Free CNTX Stock Alerts

Context Therapeutics (CNTX) Institutional Ownership

Context Therapeutics logo
$0.52 +0.02 (+3.26%)
Closing price 04:00 PM Eastern
Extended Trading
$0.52 0.00 (-0.94%)
As of 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Context Therapeutics (NASDAQ:CNTX)

Current
Institutional Ownership
Percentage
14.03%
Number of
Institutional Buyers
(last 12 months)
22
Total
Institutional Inflows
(last 12 months)
$29.06M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$15.89M
Get CNTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Context Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CNTX Institutional Buying and Selling by Quarter

Context Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2026ADAR1 Capital Management LLC750,969$416K0.0%N/A0.817%
8/13/2026 Clear Harbor Asset Management LLC92,804$51K0.0%N/A0.101%
8/11/2026 Blue Owl Capital Holdings LP2,934,015$1.63M0.2%N/A3.193%
8/8/2026 Timothy G. Youngquist 2020 Irrevocable Trust198,384$110K0.0%N/A0.216%
8/7/2026 BlackRock Inc.6,169,250$3.42M0.0%N/A6.714%
8/7/2026 Deutsche Bank AG90,882$50K0.0%N/A0.099%
8/6/2026 Bank of New York Mellon Corp109,362$61K0.0%N/A0.119%
8/6/2026 GSA Capital Partners LLP159,804$89K0.0%N/A0.174%
6/4/2026Seven Fleet Capital Management LP190,785$500K0.2%N/A0.208%
5/28/2026Avidity Partners Management LP4,998,267$13.10M2.6%-9.2%5.440%
5/19/2026Bank of America Corp DE114,888$301K0.0%+12,213.8%0.125%
5/15/2026Octagon Capital Advisors LP5,250,000$13.76M1.5%N/A5.714%
5/15/2026 OMERS ADMINISTRATION Corp80,600$211K0.0%N/A0.088%
5/14/2026 Renaissance Technologies LLC182,999$479K0.0%-64.0%0.199%
5/5/2026 Sanctuary Advisors LLC19,316$51K0.0%N/A0.021%
2/23/2026 Virtu Financial LLC28,921$43K0.0%N/A0.031%
2/18/2026XTX Topco Ltd101,605$149K0.0%+858.8%0.111%
2/18/2026 Quadrature Capital Ltd46,220$68K0.0%N/A0.050%
2/18/2026Millennium Management LLC2,601,216$3.82M0.0%N/A2.831%
2/17/2026MPM Bioimpact LLC10,679,391$15.70M1.8%-27.4%11.623%
2/16/2026Avidity Partners Management LP5,504,855$8.09M2.3%-38.7%5.991%
2/13/2026Nantahala Capital Management LLC37,837$56K0.0%-97.7%0.041%
2/13/2026 Marshall Wace LLP2,593,198$3.81M0.0%+7,153.7%2.822%
2/13/2026 State Street Corp165,607$243K0.0%+8.5%0.180%
2/12/2026 Renaissance Technologies LLC508,329$747K0.0%+58.8%0.553%
2/9/2026 Blue Owl Capital Holdings LP7,432,906$10.93M0.8%+0.3%8.090%
11/17/2025Qube Research & Technologies Ltd82,111$80K0.0%-23.1%0.089%
11/17/2025Nantahala Capital Management LLC1,661,950$1.61M0.1%-14.1%1.809%
11/17/2025Citadel Advisors LLC103,363$100K0.0%N/A0.112%
11/7/2025Vanguard Group Inc.3,495,031$3.39M0.0%+4.0%3.896%
10/23/2025 Clear Harbor Asset Management LLC92,804$90K0.0%+60.5%0.103%
8/14/2025Qube Research & Technologies Ltd106,779$70K0.0%-38.7%0.119%
8/13/2025 Affinity Asset Advisors LLC518,025$339K0.0%-21.6%0.578%
8/13/2025 Walleye Capital LLC132,786$87K0.0%-21.4%0.148%
5/16/2025Ally Bridge Group NY LLC1,157,448$708K0.6%-26.6%1.290%
5/15/2025Landscape Capital Management L.L.C.41,216$25K0.0%-54.2%0.046%
5/14/2025Affinity Asset Advisors LLC660,589$404K0.0%-34.9%0.736%
2/17/2025Velan Capital Investment Management LP90,000$94K0.1%-93.0%0.120%
2/17/2025Shay Capital LLC50,000$52K0.0%N/A0.067%
2/17/2025MPM Bioimpact LLC14,705,882$15.44M2.2%N/A19.608%
Trump’s New Currency Reset (Ad)

Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel

Watch the documentary briefing and find out which side you land on
2/17/2025Millennium Management LLC178,718$188K0.0%+24.2%0.238%
2/17/2025Citadel Advisors LLC29,900$31K0.0%N/A0.040%
2/17/2025Allostery Investments LP950,166$998K1.0%N/A1.267%
2/17/2025Ally Bridge Group NY LLC1,576,762$1.66M1.4%-10.3%2.102%
2/14/2025Jane Street Group LLC27,395$29K0.0%N/A0.037%
2/14/2025Northern Trust Corp113,565$119K0.0%-34.2%0.151%
2/14/2025Blue Owl Capital Holdings LP6,357,928$6.68M1.6%+17.5%8.477%
2/13/2025Marshall Wace LLP203,286$213K0.0%N/A0.271%
2/13/2025Affinity Asset Advisors LLC1,015,340$1.07M0.1%-23.1%1.354%
2/13/2025Walleye Capital LLC166,306$175K0.0%+51.7%0.222%
2/13/2025Renaissance Technologies LLC338,435$355K0.0%+412.8%0.451%
2/13/2025ADAR1 Capital Management LLC351,094$369K0.1%-6.1%0.468%
2/12/2025Landscape Capital Management L.L.C.90,000$94K0.0%N/A0.120%
2/12/2025Geode Capital Management LLC628,729$661K0.0%+9.2%0.838%
2/12/2025Franklin Resources Inc.4,003,380$4.20M0.0%+115.9%5.338%
1/17/2025Clear Harbor Asset Management LLC57,804$61K0.0%+60.6%0.077%
11/27/2024Franklin Resources Inc.1,853,988$3.69M0.0%N/A2.472%
11/16/2024Geode Capital Management LLC575,899$1.13M0.0%-6.8%0.768%
11/15/2024Y Intercept Hong Kong Ltd45,635$89K0.0%N/A0.061%
11/15/2024State Street Corp111,907$219K0.0%+21.5%0.149%
11/14/2024Ally Bridge Group NY LLC1,757,524$3.45M1.8%-6.8%2.343%
11/13/2024Great Point Partners LLC6,934,982$13.59M4.0%-6.5%9.247%
8/20/2024Nantahala Capital Management LLC1,935,484$3.88M0.2%N/A2.581%
8/16/2024Driehaus Capital Management LLC2,258,065$4.53M0.0%N/A3.011%
8/15/2024Blue Owl Capital Holdings LP5,161,290$10.35M2.9%N/A6.882%
8/15/2024Affinity Asset Advisors LLC1,619,140$3.25M0.4%+392.4%2.159%
8/14/2024Great Point Partners LLC7,419,355$14.88M2.8%N/A9.893%
8/14/2024Ally Bridge Group NY LLC1,886,232$3.78M2.3%+159.8%2.515%
8/9/2024Renaissance Technologies LLC65,200$131K0.0%+63.4%0.087%
5/29/2024Opaleye Management Inc.1,108,357$1.53M0.3%+13.7%1.478%
2/15/2024Opaleye Management Inc.975,000$1.10M0.3%N/A6.107%
11/15/2023Affinity Asset Advisors LLC328,817$497K0.1%+22.9%2.059%
8/21/2023Affinity Asset Advisors LLC267,574$428K0.1%N/A1.675%
7/21/2023Clear Harbor Asset Management LLC36,000$58K0.0%N/A0.225%
2/16/2023AIGH Capital Management LLC1,143,745$745K0.2%-11.5%7.162%
2/14/2023swisspartners Ltd.180,000$119K0.2%+111.8%1.127%
11/14/2022Worth Venture Partners LLC322,628$358K0.2%+8.4%2.021%
11/1/2022swisspartners Ltd.85,000$94K0.1%+101.3%0.532%
8/13/2022Virtu Financial LLC46,445$98K0.0%N/A0.291%
8/12/2022Affinity Asset Advisors LLC883,654$1.87M0.8%+13.6%5.535%


CNTX Institutional Ownership - Frequently Asked Questions

During the previous two years, 40 institutional investors and hedge funds held shares of Context Therapeutics. The most heavily invested institutionals were MPM Bioimpact LLC ($15.70M), Octagon Capital Advisors LP ($13.76M), Great Point Partners LLC ($13.59M), Avidity Partners Management LP ($13.10M), Driehaus Capital Management LLC ($4.53M), Franklin Resources Inc. ($4.20M), and Millennium Management LLC ($3.82M).Learn more on Context Therapeutics' institutional investors.

14.03% of Context Therapeutics' stock is owned by institutional investors. Learn more on CNTX's institutional investor holdings.

Of the 36 institutional investors that purchased Context Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: MPM Bioimpact LLC ($14.71M), Blue Owl Capital Holdings LP ($9.07M), Great Point Partners LLC ($7.42M), BlackRock Inc. ($6.17M), Octagon Capital Advisors LP ($5.25M), Franklin Resources Inc. ($4.00M), and Marshall Wace LLP ($2.76M).

Institutional investors have bought a total of 21,983,953 shares in the last 24 months. This purchase volume represents approximately $29.06M in transactions.

The following institutional investors have sold Context Therapeutics stock in the last 24 months: MPM Bioimpact LLC ($4.03M), Avidity Partners Management LP ($3.98M), Nantahala Capital Management LLC ($1.90M), Renaissance Technologies LLC ($325.33K), and Qube Research & Technologies Ltd ($24.67K).

Institutional investors have sold a total of 10,257,724 shares in the last 24 months. This volume of shares sold represents approximately $15.89M in transactions.


Related Companies

Institutional ownership data for NASDAQ:CNTX is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/14/2026. New 13F filings are added each quarter as they're published.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
AI insiders stockpile guns, gold & gas masks
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Who Really Gets Rich from IPOs?
Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...
Weiss Ratings | Sponsoredtc pixel
$100 for this… $500 for that. Here’s how to stop the bleeding today
Rising costs are squeezing households nationwide. USA Today reports more families are moving in together, whil...
Brownstone Research | Sponsoredtc pixel